Takeda Pharmaceuticals America, Inc.
Drug manufacturer · manufacturer
Unclaimed listing
147
Drug products
6
Therapeutic areas
About
Takeda Pharmaceuticals America, Inc. is listed in the FDA National Drug Code Directory with 147 marketed products, of which 104 are prescription drugs. Dosage forms include SOLUTION, INJECTION, KIT, CAPSULE, TABLET. Portfolio includes DEA-scheduled controlled substances.
What Takeda Pharmaceuticals America, Inc. makes
147 productsOther · 99CNS & Psychiatry · 23Injectable & Infusion · 18Gastrointestinal · 5Diabetes & Metabolic · 1Immunology & Inflammation · 1
- HEMOFIL Mantihemophilic factor human
- HEMOFIL Mantihemophilic factor human
- HEMOFIL Mantihemophilic factor human
- HEMOFIL Mantihemophilic factor human
- RECOMBINATEantihemophilic factor recombinant
- RECOMBINATEantihemophilic factor recombinant
- RECOMBINATEantihemophilic factor recombinant
- RECOMBINATEantihemophilic factor recombinant
- RECOMBINATEantihemophilic factor recombinant
- ADZYNMAapadamtase alfa
- ADZYNMAapadamtase alfa
- VELCADEbortezomib
- Alunbrigbrigatinib
- Alunbrigbrigatinib
- Alunbrigbrigatinib
- Alunbrigbrigatinib
- Eohiliabudesonide
- Carbatrolcarbamazepine
- Carbatrolcarbamazepine
- Carbatrolcarbamazepine
Get a price
This listing is unclaimed, so post your requirement and every verified pharmacy licensed in your state will bid.
Request a quoteContact
Email and website are not published in the public registries — they are added when the listing is claimed.
From the FDA NDC Directory, refreshed 2026-08-15.
Is this your business?
Claim the listing to publish your catalog, answer buyer enquiries and bid on sourcing requests.
Claim this listing